×
Back to Agenda
Session 5: Brexit Time Check: What’s Next for Medicines?
Session Chair(s)
Peter O'Donnell
Journalist, Belgium
The aim of this session is to get to the broader level vision of what’s coming next in the Brexit schedule of change. This session will bring together a broad range of stakeholders to contribute their expectations, concerns and needs for the next stages of Brexit and the future partnership arrangements.
Speaker(s)
Robert Andrew Johnstone
Patient Representative, The International Foundation for Integrated Care (IFIC), United Kingdom
Virginia Acha
AVP, Science and Regulatory Policy, Merck & Co., Inc., United Kingdom
Elizabeth Kuiper, MA
Executive Director, Public Affairs, European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium
Oliver Sude, PhD
Legal Counsel, EU Affairs, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), Belgium
Have an account?